The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Open accessAbstract
Drug resistance remains a major obstacle to successful cancer treatment. A database of drug-associated gene expression profiles was screened for molecules whose profile overlapped with a gene expression signature of glucocorticoid (GC) sensitivity/resistance in acute lymphoblastic leukemia (ALL) cells. The screen indicated that the mTOR inhibitor rapamycin profile matched the signature of GC sensitivity. We tested the hypothesis that rapamycin would induce GC sensitivity in lymphoid malignancy cells and found that it sensitized to GC-induced apoptosis via modulation of antiapoptotic MCL1. These data indicate that MCL1 is an important regulator of GC-induced apoptosis and that the combination of rapamycin and glucocorticoids has potential utility in lymphoid malignancies. Furthermore, this approach represents a strategy for identification of promising combination therapies for cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Bouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504
Lindsten, T., Ross, A. J., King, A., Zong, W.-X., Rathmell, J. C., Shiels, H. A., Ulrich, E., Waymire, K. G., Mahar, P., Frauwirth, K., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00136-2 · Cited by 1,489
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Certo, M., Moore, V. D. G., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S. A., & Letai, A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.027 · Cited by 1,288
Self-citationbcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Self-citationSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Self-citationHolleman, A., Cheok, M. H., den Boer, M. L., Yang, W., Veerman, A. J. P., Kazemier, K. M., Pei, D., Cheng, C., Pui, C.-H., Relling, M. V., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033513 · Cited by 633
Self-citationElimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F., & Wang, X. (2003) · Genes & Development · doi:10.1101/gad.1093903 · Cited by 591
Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells
Opferman, J. T., Iwasaki, H., Ong, C. C., Suh, H., Mizuno, S.-I., Akashi, K., & Korsmeyer, S. J. (2005) · Science · doi:10.1126/science.1106114 · Cited by 574
Self-citationApoptosis in the development and maintenance of the immune system
Opferman, J. T., & Korsmeyer, S. J. (2003) · Nature Immunology · doi:10.1038/ni0503-410 · Cited by 526
Self-citationAn expanding role for mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.007 · Cited by 523
Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
Reed, J. C. (1995) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199511000-00012 · Cited by 479
A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer
Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., & Ewen, M. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00570-1 · Cited by 416
Self-citationArmstrong, S. A., Kung, A. L., Mabon, M. E., Silverman, L. B., Stam, R. W., Den Boer, M. L., Pieters, R., Kersey, J. H., Sallan, S. E., Fletcher, J. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00003-5 · Cited by 398
Self-citationBcl-XL and Bcl-2 repress a common pathway of cell death.
Chao, D. T., Linette, G. P., Boise, L. H., White, L. S., Thompson, C. B., & Korsmeyer, S. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.821 · Cited by 395
Peng, T., Golub, T. R., & Sabatini, D. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5575-5584.2002 · Cited by 395
Self-citationWang, J.-M., Chao, J.-R., Chen, W., Kuo, M.-L., Yen, J. J.-Y., & Yang-Yen, H.-F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6195 · Cited by 357
Dördelmann, M., Reiter, A., Borkhardt, A., Ludwig, W.-D., Götz, N., Viehmann, S., Gadner, H., Riehm, H., & Schrappe, M. (1999) · Blood · doi:10.1182/blood.v94.4.1209 · Cited by 341
The Role of Apoptosis in the Regulation of Hematopoietic Stem Cells
Domen, J., Cheshier, S. H., & Weissman, I. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.253 · Cited by 333
Mondesire, W. H., Jian, W., Zhang, H., Ensor, J., Hung, M.-C., Mills, G. B., & Meric-Bernstam, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0361 · Cited by 319
Kaspers, G. J. L., Veerman, A. J. P., Pieters, R., Van Zantwijk, C. H., Smets, L. A., Van Wering, E. R., & Van Der Does-Van Den Berg, A. (1997) · Blood · doi:10.1182/blood.v90.7.2723 · Cited by 271
Self-citationGene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation
Stegmaier, K., Ross, K. N., Colavito, S. A., O'Malley, S., Stockwell, B. R., & Golub, T. R. (2004) · Nature Genetics · doi:10.1038/ng1305 · Cited by 268
Self-citationErlacher, M., Michalak, E. M., Kelly, P. N., Labi, V., Niederegger, H., Coultas, L., Adams, J. M., Strasser, A., & Villunger, A. (2005) · Blood · doi:10.1182/blood-2005-04-1595 · Cited by 264
Wang, Z., Malone, M. H., He, H., McColl, K. S., & Distelhorst, C. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301843200 · Cited by 222
Pieters, R., Huismans, D. R., Loonen, A. H., Veerman, A. J. P., Hahlen, K., van der Does-van den Berg, A., & Wering, E. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)91029-t · Cited by 216
Self-citationAn Expression Signature Classifies Chemotherapy-Resistant Pediatric Osteosarcoma
Mintz, M. B., Sowers, R., Brown, K. M., Hilmer, S. C., Mazza, B., Huvos, A. G., Meyers, P. A., LaFleur, B., McDonough, W. S., Henry, M. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2463 · Cited by 215
Liu, H., Perlman, H., Pagliari, L. J., & Pope, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.2.113 · Cited by 208
Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease
Takeuchi, O., Fisher, J., Suh, H., Harada, H., Malynn, B. A., & Korsmeyer, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504783102 · Cited by 203
Den Boer, M. L., Harms, D. O., Pieters, R., Kazemier, K. M., Göbel, U., Körholz, D., Graubner, U., Haas, R. J., Jorch, N., Spaar, H. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.031 · Cited by 184
Self-citationInhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice.
Siegel, R. M., Katsumata, M., Miyashita, T., Louie, D. C., Greene, M. I., & Reed, J. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7003 · Cited by 181
Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma
Memon, S. A., Moreno, M. B., Petrak, D., & Zacharchuk, C. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4644 · Cited by 172
Grillot, D. A., Merino, R., & Núñez, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1973 · Cited by 172
Kaspers, G. J. L., Pieters, R., Van Zantwijk, C. H., VanWering, E. R., Van Der Does-Van Den Berg, A., & Veerman, A. J. P. (1998) · Blood · doi:10.1182/blood.v92.1.259.413k21_259_266 · Cited by 168
Self-citationMolecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia
Tissing, W. J. E., Meijerink, J. P. P., den Boer, M. L., & Pieters, R. (2003) · Leukemia · doi:10.1038/sj.leu.2402733 · Cited by 167
Self-citationZhou, P., Qian, L., Bieszczad, C. K., Noelle, R. J., Binder, M., Levy, N. B., & Craig, R. W. (1998) · Blood · doi:10.1182/blood.v92.9.3226 · Cited by 157
Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia
Schmidt, S. U., Rainer, J., Riml, S., Ploner, C., Jesacher, S., Achmüller, C., Presul, E., Skvortsov, S., Crazzolara, R., Fiegl, M., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2853 · Cited by 149
Hongo, T., Yajima, S., Sakurai, M., et al. (1997) · Blood · doi:10.1182/blood.v89.8.2959 · Cited by 140
Abrams, M. T., Robertson, N. M., Yoon, K., & Wickstrom, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411767200 · Cited by 122
Bachmann, P. S., Gorman, R., MacKenzie, K. L., Lutze-Mann, L. H., & Lock, R. B. (2004) · Blood · doi:10.1182/blood-2004-05-2023 · Cited by 99
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.
Heuser, M., Wingen, L. U., Steinemann, D., Cario, G., Neuhoff, N. V., Tauscher, M., Bullinger, L., Krauter, J., Heil, G., Döhner, H., et al. (2005) · PubMed · Cited by 84
Kasukabe, T., Okabe‐Kado, J., Kato, N., Sassa, T., & Honma, Y. (2005) · Breast Cancer Research · doi:10.1186/bcr1344 · Cited by 62
Hartmann, B. L., Geley, S., Loeffler, M. W., Hattmannstorfer, R., Strasser-Wozak, E. M., Auer, B., & Kofler, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202339 · Cited by 52
Activated Ets2 Is Required for Persistent Inflammatory Responses in the Motheaten Viable Model
Guo, W., Guo, J., Doseff, A. I., Kusewitt, D. F., Man, A. K., Oshima, R. G., & Ostrowski, M. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1374 · Cited by 51
Gene expression determinants of clinical outcome
Buckhaults, P. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198022.76476.b2 · Cited by 14
Cited by
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945
Self-citationMetabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Hata, A. N., Engelman, J. A., & Faber, A. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0011 · Cited by 619
Enabling personalized cancer medicine through analysis of gene-expression patterns
van 't Veer, L. J., & Bernards, R. (2008) · Nature · doi:10.1038/nature06915 · Cited by 554
Metadata
- Authors
- Wei, G., Twomey, D., Lamb, J., Schlis, K., Agarwal, J., Stam, R. W., Opferman, J. T., Sallan, S. E., den Boer, M. L., Pieters, R., Golub, T. R., & Armstrong, S. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 10
- Issue
- 4
- Pages
- 331-342
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1988377311
- Cited by
- 509
- References
- 60
- FWCI
- 34.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.